Company page
Sellas Life Sciences Group, Inc.
Sellas Life Sciences Group, Inc. is a public company traded under the ticker RXK3 in the German market. The company has a market capitalization of approximately €1.5 billion. Sellas focuses on developing innovative therapies for cancer treatment, aiming to address unmet medical needs in oncology.
- Ticker
- SLS:NASDAQ
- Asset type
- Stock
- Market cap
- $1.50B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD